• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Protein kinase C--a novel target for rational anti-cancer drug design?

作者信息

Gescher A, Dale I L

机构信息

Pharmaceutical Sciences Institute, Aston University, Birmingham, UK.

出版信息

Anticancer Drug Des. 1989 Aug;4(2):93-105.

PMID:2679620
Abstract
摘要

相似文献

1
Protein kinase C--a novel target for rational anti-cancer drug design?
Anticancer Drug Des. 1989 Aug;4(2):93-105.
2
Combination chemotherapy--theory and practice.联合化疗——理论与实践
Semin Oncol. 1977 Jun;4(2):227-53.
3
In search of novel molecular targets in cancer: the diacyglycerol pathways.寻找癌症中的新型分子靶点：二酰甘油途径。
Hawaii Med J. 2004 Oct;63(10):318-9, 321.
4
The inhibition of protein phosphatases 1 and 2A: a new target for rational anti-cancer drug design?蛋白磷酸酶1和2A的抑制作用：合理设计抗癌药物的新靶点？
Anticancer Drug Des. 2001 Dec;16(6):291-303.
5
[Protein kinase C. Key enzyme for immune reactions and cell growth].[蛋白激酶C。免疫反应和细胞生长的关键酶]
Med Monatsschr Pharm. 1994 Nov;17(11):326-8.
6
The place of pharmacology in cancer medicine.药理学在癌症医学中的地位。
Semin Oncol. 1977 Jun;4(2):131-3.
7
Preclinical and clinical development of novel agents that target the protein kinase C family.靶向蛋白激酶C家族的新型药物的临床前和临床开发。
Semin Oncol. 2006 Aug;33(4):466-78. doi: 10.1053/j.seminoncol.2006.04.009.
8
Issues and progress with protein kinase inhibitors for cancer treatment.用于癌症治疗的蛋白激酶抑制剂的问题与进展
Nat Rev Drug Discov. 2003 Apr;2(4):296-313. doi: 10.1038/nrd1066.
9
Design, synthesis and biological evaluation of novel compounds with conjugated structure as anti-tumor agents.具有共轭结构的新型化合物作为抗肿瘤药物的设计、合成及生物学评价
Bioorg Med Chem. 2008 Sep 1;16(17):7992-8002. doi: 10.1016/j.bmc.2008.07.066. Epub 2008 Jul 29.
10
Antisense oligonucleotide inhibitors of isozymes of protein kinase C: in vitro and in vivo activity, and clinical development as anti-cancer therapeutics.蛋白激酶C同工酶的反义寡核苷酸抑制剂：体外和体内活性以及作为抗癌治疗药物的临床开发
Anticancer Drug Des. 1997 Jul;12(5):315-26.

引用本文的文献

1
Isolation and characterization of a novel zinc finger gene, ZNFD, activating AP1(PMA) transcriptional activities.分离并鉴定一种新型锌指基因 ZNFD，其可激活 AP1（PMA）转录活性。
Mol Cell Biochem. 2010 Jul;340(1-2):63-71. doi: 10.1007/s11010-010-0401-1. Epub 2010 Feb 18.
2
A phase I trial of daily oral 4'- N -benzoyl-staurosporine in combination with protracted continuous infusion 5-fluorouracil in patients with advanced solid malignancies.一项针对晚期实体恶性肿瘤患者的Ⅰ期试验，每日口服4'-N-苯甲酰基-星形孢菌素联合持续输注5-氟尿嘧啶。
Invest New Drugs. 2004 Apr;22(2):139-50. doi: 10.1023/B:DRUG.0000011790.31292.ef.
3
Protein kinase C targeting in antineoplastic treatment strategies.
抗肿瘤治疗策略中的蛋白激酶C靶向作用
Invest New Drugs. 1999;17(3):227-40. doi: 10.1023/a:1006328303451.
4
In vitro antitumour activity of the novel imidazoisoquinoline SDZ 62-434.新型咪唑异喹啉SDZ 62-434的体外抗肿瘤活性
Br J Cancer. 1993 May;67(5):989-95. doi: 10.1038/bjc.1993.181.
5
Cell-signaling targets for antitumour drug development.用于抗肿瘤药物研发的细胞信号转导靶点。
Cancer Chemother Pharmacol. 1993;32(1):1-19. doi: 10.1007/BF00685870.
6
Cancer chemotherapy: identifying novel anticancer drugs.癌症化疗：寻找新型抗癌药物。
BMJ. 1994 May 14;308(6939):1288-90. doi: 10.1136/bmj.308.6939.1288.
7
Inhibition of protein kinase C-alpha expression in mice after systemic administration of phosphorothioate antisense oligodeoxynucleotides.全身给予硫代磷酸酯反义寡脱氧核苷酸后小鼠蛋白激酶C-α表达的抑制
Proc Natl Acad Sci U S A. 1994 Nov 22;91(24):11762-6. doi: 10.1073/pnas.91.24.11762.